Delivery Order SPE2DB25D3012-SPE2DB25FWZUL
- Not listed
- The Defense Logistics Agency (DLA) awarded a $34,883.25 delivery order to AmerisourceBergen Drug Corp for the supply of LEQVIO 284 mg/1.5 mL syringes. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 14, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $34,883.25 to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Leqvio 284 mg/1.5 mL syringes. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This delivery order, awarded August 4, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides LEQVIO 284 mg/1.5 mL syringes valued at $9.3K with a completion date of August 25, 2025. The contract utilizes firm fixed pricing with no set-aside designation, reflecting open and competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency Troop Support Medical awarded a $8,679.24 delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4562342128 LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. Performance will take place in Conshohocken, Pennsylvania under a firm fixed price arrangement concluding in October 2023. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen Drug Corp will deliver the requested LEQVIO injectable medication to support the Defense Logistics...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,651.10, is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, a medical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 21, 2025. The contract is not set aside for any specific business type. In addition to this delivery order,...
- The Defense Logistics Agency awarded a $6,976.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 1.5 milliliter syringes containing Leqvio 284 mg. The contract, which is not set-aside, was awarded on September 2, 2025, with a completion date of September 23, 2025. Performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $2,197.41 firm fixed price delivery order contract to provide LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
- The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the procurement of Leqvio 284 mg/1.5 ml syringes. The Firm Fixed Price contract, valued at $21,974.10, has an ultimate completion date of August 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, with a ceiling value of $4,651.10 and a completion date of July 23, 2025. The contract is a firm fixed-price, non-set-aside delivery order, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $21,974.10 firm-fixed-price delivery order is for the supply of LEQVIO 284 MG/1.5 ML syringes. Amerisourcebergen is a major pharmaceutical distributor that holds several indefinite delivery contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range of medical commodities to...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWZULDelivery Order
The Defense Logistics Agency awarded a $46,511 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of LEQVIO 284 mg/1.5 mL syringes, with an ultimate completion date of September 25, 2025. This competitively awarded contract contains no set-aside designation and specifies performance at AmerisourceBergen's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999 global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of delivery orders with the Defense Logistics Agency covering a broad range of pharmaceutical products and medical supplies for military and veteran healthcare systems. This specific award for LEQVIO, a cholesterol management medication, exemplifies the company's role in supporting the Defense Health Agency and other government healthcare systems through flexible contract vehicles designed to meet diverse and ongoing pharmaceutical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $46.5k | 9/4/25 |